Literature DB >> 30663668

Development and Angiographic Use of the Rabbit VX2 Model for Liver Cancer.

Ramzy C Khabbaz1, Yu-Hui Huang1, Alexandra A Smith2, Kelly D Garcia3, R Peter Lokken3, Ron C Gaba4.   

Abstract

The rabbit VX2 tumor is an animal model commonly utilized for translational research regarding hepatocellular carcinoma (HCC) in the field of Interventional Radiology. This model employs an anaplastic squamous cell carcinoma that is easily and reliably propagated in the skeletal muscle of donor rabbits for eventual harvest and allograft implantation into the liver of naïve recipients. This tumor graft rapidly grows within the liver of recipient rabbits into an angiographically identifiable tumor characterized by a necrotic core surrounded by a viable hypervascular capsule. The physical size of the rabbit anatomy is sufficient to facilitate vascular instrumentation allowing for the application and testing of various interventional techniques. Despite these benefits, there exists a paucity of technical resources to act as a concrete reference for researchers working with the model. Herein, we present a comprehensive visual outline for the technical aspects of development, growth, propagation, and angiographic utilization of the rabbit VX2 tumor model for use by novice and experienced researchers alike.

Entities:  

Year:  2019        PMID: 30663668     DOI: 10.3791/58600

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

1.  Treatment for Liver Tumor Using Combined Transarterial Embolization and Interaarterial Transfecting HIF-1α shRNA in a Rabbit VX2 Model.

Authors:  Chuangen Guo; Cheng Wang; Jingfeng Zhang; Xiao Chen
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

2.  On-demand degradable embolic microspheres for immediate restoration of blood flow during image-guided embolization procedures.

Authors:  Hyunjun Choi; Bongseo Choi; Bo Yu; Weiguo Li; Monica M Matsumoto; Kathleen R Harris; Robert J Lewandowski; Andrew C Larson; Samdeep K Mouli; Dong-Hyun Kim
Journal:  Biomaterials       Date:  2020-09-24       Impact factor: 12.479

Review 3.  Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma.

Authors:  Charlotte Ebeling Barbier; Femke Heindryckx; Hans Lennernäs
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.